Dextran 70 6%+0.9% (IV Infusion)
Not for sale
Medicine Details
| Category | Details |
|---|---|
| Generic | Dextran sodium chloride |
| Company | Institute of public health iph |
| Also available as |
Indications
- Aid in Hysteroscopy
- Thromboembolic disorders
- Prophylaxis of pulmonary embolism or venous thrombosis in moderate- to high-risk patients undergoing surgery
- Prophylaxis of postoperative thromboembolic disorders
- Hypovolaemic shock
Pharmacology
- Dextran produces expansion of plasma volume
- Reduction of blood viscosity
- Inhibition of sludging or aggregation of red blood cells
- Sodium chloride's role in electrolyte and fluid balance
- Osmotic pressure control
- Water distribution and restoration of sodium ions
Dosage & Administration
- Intrauterine usage for aid in hysteroscopy
- Intravenous usage for thromboembolic disorders
- Intravenous usage for prophylaxis of pulmonary embolism or venous thrombosis in patients undergoing surgery
- Intravenous usage for prophylaxis of postoperative thromboembolic disorders
- Intravenous usage for treatment of hypovolaemic shock
Interaction
- Enzyme inducers affecting dextran
- Enzyme inhibitors affecting dextran
- Potential effect on serum concentrations of lithium by sodium chloride
Contraindications
- Hypersensitivity
- Severe renal disease with oliguria or anuria
- Marked cardiac decompensation
- Pregnancy
Side Effects
- GI disturbances
- Headache
- Dizziness
- Allergic reactions
- Raised liver enzyme values
- Alopecia
- Bone marrow suppression
Pregnancy & Lactation
- Category C: Usage only if potential benefit justifies the potential risk to the foetus
Precautions & Warnings
- Lactation
Therapeutic Class
- Plasma expanders
Storage Conditions
- Store at 25°C